A Clinical Study in Subjects With Neuropathic Pain From PHN Who Have Had an Inadequate Response to Gabapentin Treatment
Status:
Completed
Trial end date:
2009-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is evaluate the difference between two doses of gabapentin
enacarbil (XP13512/GSK1838262), hereafter referred to as GEn, on pain associated with
post-herpetic neuralgia.